ACB weekly long setup with pot sector finding a bottom.

Pot names love to run into the near year and ACB never ran this year like its other peers CRON, TLRY, CGC and has higher sales than all three. The only thing the company lacks is a beverage deal which will most likely attain in the future. All imo.